| 注册
首页|期刊导航|中国药理学与毒理学杂志|阿尔茨海默病与肠道菌群的关系及菌群调节对其防治的展望

阿尔茨海默病与肠道菌群的关系及菌群调节对其防治的展望

周珂新 徐雷艇 马银娟 周佳思 戴嘉佳 梁丽丽 魏华

中国药理学与毒理学杂志2016,Vol.30Issue(11):1198-1205,8.
中国药理学与毒理学杂志2016,Vol.30Issue(11):1198-1205,8.DOI:10.3867/j.issn.1000-3002.2016.11.011

阿尔茨海默病与肠道菌群的关系及菌群调节对其防治的展望

Relationships between intestinal microbiota and Alzheimer disease and regulation of microbiota on prevention and treatment of Alzheimer disease:review

周珂新 1徐雷艇 1马银娟 1周佳思 1戴嘉佳 1梁丽丽 1魏华1

作者信息

  • 1. 宁波大学医学院病理学与病原生物学实验室,浙江省病理生理学技术研究重点实验室,糖尿病研究中心,浙江宁波 315211
  • 折叠

摘要

Abstract

With the extension of human life,the number of patients with Alzheimer disease(AD) is increaseing. However,the mechanisms of AD are still not very clear and there is no effective preven⁃tion and treatment process for this disease. In recent years,the importance of intestinal microbiota in the health field has been gradually elaborated,which has become a new research area for AD. There is chronic inflammation,a low level of neurotransmitter 5-hydroxy tryptamine and neurotrophic factor in the central nervous system of AD patients,and a changed structure of AD intestinal microbiota. The intestinal microbiota can cause chronic inflammation,produce neurotoxic substances,and may be related to obesity,type 2 diabetes and other metabolic diseases which are AD high-risk disease, suggesting the correlation between AD and intestinal microbiota. Intestinal microbiota can be regulated by probiotics , prebiotics and traditional Chinese materia medica and beneficial microbiota can reduce inflammation and the occurrence of metabolic syndrome such as diabetes,increase the level of brain neurotransmitter 5-hydroxytryptamine and neurotrophic factor and improve cognitive function. Intestinal microbiota regu⁃lation may become a new approach to the prevention and treatment of AD.

关键词

阿尔茨海默病/肠道菌群/代谢物

Key words

Alzheimer disease/intestinal microbiota/metabolites

分类

生物科学

引用本文复制引用

周珂新,徐雷艇,马银娟,周佳思,戴嘉佳,梁丽丽,魏华..阿尔茨海默病与肠道菌群的关系及菌群调节对其防治的展望[J].中国药理学与毒理学杂志,2016,30(11):1198-1205,8.

基金项目

国家自然科学基金(31600402);浙江省病理生理学技术研究重点实验室人才引进基金项目(ZJKLP201401);浙江省自然科学基金项目(Y16H070001);宁波大学科研基金项目(XKL14D2106);宁波大学科研基金项目(XYL14021);宁波大学科研基金项目(ZX2014000128)@@@@The project supported by National Natural Science Foundation of China(31600402);Zhejiang Pro-vincial Key Laboratory of Pathophysiology Fund Project (ZJKLP201401);Natural Science Fund Project of Zhejiang Province(Y16H070001);Ningbo University Scientific Research Fund Project(XKL14D2106);Ningbo University Scien-tific Research Fund Project(XYL14021);and Ningbo University Scientific Research Fund Project ()

中国药理学与毒理学杂志

OA北大核心CSCDCSTPCD

1000-3002

访问量0
|
下载量0
段落导航相关论文